Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials


This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the anticipated benefits of the transaction, including future financial and operating performance, and the anticipated timing for completing the transaction. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “guidance,” “expect,” “assume,” “anticipate,” “intend,” “plan,” “forecast,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results could differ materially from these forward looking statements due to a number of factors, including, but not limited to:  the parties’ ability to meet expectations regarding the accounting and tax treatments of the proposed transaction; the anticipated benefits of the acquisition may not be realized, or may be realized more slowly or to a lesser extent than expected, difficulties, delays, costs or disruptions associated with integrating the acquired business, operations, employees, systems and processes into the Company, the ability to retain existing customers and business relationships of the acquired operations and win new business following the acquisition, the ability to retain and integrate key employees of the acquired business, the parties’ ability to perform their respective obligations under transition services and other agreements, unanticipated liabilities, expenses or adverse effects associated with the acquired business, the ability to maintain applicable regulatory, quality and accreditation requirements for the acquired sites, and other factors described from time to time in documents that the Company files with the SEC. For a further discussion of the risks relating to the Company’s business, see the “Risk Factors” Section of the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission (the “SEC”), as such factors may be amended or updated from time to time in the Company’s subsequent periodic and other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included or incorporated by reference in this report and in the Company’s filings with the SEC. All forward-looking statements are made only as of the date of this report and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments. 



Source link

  • Related Posts

    Belgravia Announces Proposed Share Consolidation

    This press release contains forward-looking statements regarding Belgravia and the Consolidation. Forward-looking statements are based on current expectations and are subject to risks, uncertainties, regulatory requirements, technical dependencies, product validation,…

    Continue reading
    S&P/TSX composite index down nearly 250 points, U.S. markets mixed

    TORONTO — Canada’s main stock index fell nearly 250 points on Monday, weighed down by broad losses, while U.S. markets were mixed. The S&P/TSX composite index was down 247.92 points…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Canada v England: How have Canada closed gap to Red Roses?

    Canada v England: How have Canada closed gap to Red Roses?

    Amazon is taking its biggest shot at Nvidia yet with new TorchNeuron dev tool

    Amazon is taking its biggest shot at Nvidia yet with new TorchNeuron dev tool

    Eagles coach defends handling of Jalen Hurts’ blood clots diagnosis: What to know

    Eagles coach defends handling of Jalen Hurts’ blood clots diagnosis: What to know

    7 Editor-Favorite Gap Items on Sale Right Now

    7 Editor-Favorite Gap Items on Sale Right Now

    Dead and injured following attacks on Ebola responders in the Democratic Republic of the Congo

    Dead and injured following attacks on Ebola responders in the Democratic Republic of the Congo

    Tuesday, October 20, 2026

    Tuesday, October 20, 2026